Professional Activities
Philadelphia Bar Foundation, President, 2019-present; Vice President, 2007-2018; Board of Trustees, 2010-present; Secretary, 2013-2016; Co-Chair, 50th Anniversary Gala
Philadelphia Diversity Law Group, Co-President, 2019-present; Vice President, 2016-2018; Board of Directors, 2011-present
Forum of Executive Women, 2017-present
WOMEN'S WAY (nation's oldest women's funding federation), General Counsel, 2007-present
Ballard Spahr's Diversity and Inclusion Council, Member
Recognition & Accomplishments
The Legal 500 US, Antitrust - Civil litigation/class action - defense and plaintiff, 2019-2020
Chambers USA, antitrust law (Pennsylvania), 2014-2020
Benchmark Litigation, "Local Litigation Star," Commercial Litigation, Antitrust, Securities, 2011-2021; named one of the "Top 250 Women in Litigation," 2012-2017, 2019
Named to The Legal Intelligencer's "Top Women in Law," 2016
Named Litigator of the Week by Global Competition Review in July 2015
Recipient, Albert S. Dandridge, III Business Law Section Diversity Award, presented by the Business Law Section of the Philadelphia Bar Association, 2014
Publications
Co-author, "Ninth Circuit Reverses Trial Court’s Finding That Qualcomm Violated Antitrust Laws," Ballard Spahr alert, August 14, 2020
Co-author, "FTC and DOJ Announce Monitoring of Employer Coordination that Disadvantages Workers During COVID-19," Ballard Spahr alert, April 15, 2020
Co-author, "FTC and DOJ Announce Expedited Antitrust Procedure and Guidance for Coronavirus Public Health Efforts," Ballard Spahr alert, March 25, 2020
Co-author, "DOJ Says It Will Be on the Lookout for Antitrust Violations During COVID-19 Outbreak," Ballard Spahr alert, March 11, 2020
Co-author, "$5 Million Penalty Underscores Importance of Antitrust Compliance in M&A Transactions," Ballard Spahr alert, June 11, 2019
Co-author, "Employers, Beware: DOJ, FTC Mean Business With Enhanced Antitrust Enforcement Efforts," Ballard Spahr alert, October 30, 2018
Co-author, "Does Your Antitrust Compliance Policy Cover All It Should Under HSR?" Ballard Spahr alert, May 24, 2018
Co-author, "FTC Scores Another Victory in FTC v. Advocate Health Care Network," Ballard Spahr alert, November 1, 2016
Co-author, "FTC and DOJ Release Antitrust Guidance for HR Professionals," Ballard Spahr alert, October 21, 2016
Co-author, "FTC Wins Key Appellate Victory in FTC v. Penn State Hershey Medical Center," Ballard Spahr alert, September 27, 2016
Co-author, "FTC's Hospital Merger Enforcement Hangs in the Balance," Law360, June 16, 2016
Co-author, "FTC Finally Loses a Hospital Merger Challenge … Now What?" Ballard Spahr alert, May 11, 2016
Co-author, "Court Rules NCAA Can Block Colleges from Paying Student-Athletes, But Allows Scholarships for 'Full Cost of Attendance'," Ballard Spahr alert, September 30, 2015
Co-author, "CA Supreme Court Issues First Decision Extending FTC v. Actavis to State Antitrust Litigation," Ballard Spahr alert, May 7, 2015
Co-author, "Speed of Pharmaceutical Innovation at Stake in N.Y. Antitrust Lawsuit," Ballard Spahr alert, January 21, 2015
Co-author, "2 Assumptions Shape 3rd Circ. Reverse Payment Case," Law360, November 20, 2014
Co-author, "'Reverse Payment' Realities: Challenging Pervasive Assumptions Underlying Calls for Broad Antitrust Scrutiny of Patent Infringement Settlements," Bloomberg BNA Antitrust & Trade Regulation Report, November 14, 2014
Co-author, "The Corporate Antitrust Policy—Privileged or Not?" Law360, November 7, 2014
Co-author, "Court Finds Attorney-Client Privilege Did Not Protect Antitrust Policy Disclosure," Ballard Spahr alert, October 14, 2014
Co-author, "4 Trends in FTC Antitrust Regulation and Enforcement," Law360, August 25, 2014
Co-author, "FTC and DOJ Shine the Spotlight on Conditional Pricing Practices," Ballard Spahr alert, June 25, 2014
Co-author, "Court Endorses FTC Authority To Require Special Reporting for Pharmaceutical Licenses," Ballard Spahr alert, June 4, 2014
Co-author, "HSR Act Allows Pharmaceutical Licensing Transactions To Be Subject to Unique Reporting Requirements, FTC Tells Court," Ballard Spahr alert, March 13, 2014
Co-author, "'The Past Is Never Dead': FTC Requires Divestiture of Acquisition Five Years After Deal Closed," Ballard Spahr alert, December 26, 2013
Co-author, "FTC Issues Premerger Notification Review Changes for Pharmaceutical Patent License Transfers," Ballard Spahr alert, November 7, 2013
Co-author, "Little Guidance for Lower Courts in FTC v. Actavis," Today's General Counsel, August/September 2013
Co-author, "Supreme Court Chooses Middle Ground in Assessing Reverse Payment Settlements," Ballard Spahr alert, June 17, 2013
Co-author, "Supreme Court Requires Proof at Certification Stage that Damages Can Be Measured on Class-Wide Basis," Ballard Spahr alert, March 29, 2013
Co-author, "Supreme Court Hands FTC Victory on State Action Immunity," Ballard Spahr alert, February 21, 2013
"ZF Meritor, LLC v. Eaton Corporation Case Summary," The Price Point, Newsletter of the ABA Section of Antitrust Law Pricing Conduct Committee, Fall 2012
Co-author, "Price-Cost Test Does Not Apply in Exclusive Dealing Cases Where Pricing Is Not the Exclusionary Tool, Third Circuit Holds, While Circumscribing Prior Holding in LePage's," Ballard Spahr alert, October 3, 2012
Co-author, "Signaling Intention To Pursue Monetary Remedies in Competition Cases, FTC Withdraws Policy Statement," Ballard Spahr alert, August 2, 2012
Co-author, "DOJ and FTC Announce Antitrust Enforcement Policy Regarding Accountable Care Organizations," Ballard Spahr alert, November 1, 2011
Co-author, "Buyer (and Seller) Beware: Changes to Hart-Scott-Rodino Notification Requirements Critical to M&As," Ballard Spahr alert, August 16, 2011
Co-author, "DOJ and FTC Issue New Guidelines for Review of Mergers and Acquisitions," Ballard Spahr alert, August 20, 2010
Co-author, "Justice Department Announcement of $12 Million Settlement Signals Renewed Antitrust Scrutiny on Energy Markets," Ballard Spahr alert, February 23, 2010
Co-author, "Unjust Enrichment: Unjust, Indeed," Law360, December 8, 2008
Speaking Engagements
Speaker, "Antitrust and the New Administration: Insights Into Enforcement and Policy, and What Companies Should Do Now to Prepare," Ballard Spahr webinar, December 3, 2020
Speaker, "Antitrust in the Time of COVID-19: Pricing Issues and Dealing With Competitors," Ballard Spahr webinar, June 16, 2020
Speaker, "Antitrust in Today's Political Environment," Ballard Spahr webinar, March 26, 2020
Speaker, "The Trouble With Trebles," Ballard Spahr CLE Program, October 16, 2018
Speaker, Hot Topics in NY Antitrust: Class Certification and Fraud-Based Antitrust Investigations," New York City Bar's Antitrust & Trade Regulation Committee, April 30, 2018
Speaker, "Post-Lamictal, Loestrin & Nexium: What Violates Section One Reverse Payment Law, and What Does Not?" HarrisMartin's Pharmaceutical Antitrust Litigation Conference: Generic Drugs & Emerging Price-Fixing cases, March 3, 2017
Speaker, "Everyday Antitrust Issues: You Don’t Know What You Don't Know," Ballard Spahr CLE Program, October 12, 2017
Panelist, "Recent Issues in Reverse Payment Litigation," Health Care and Pharmaceuticals Committee of the ABA Section of Antitrust Law, September 14, 2017
Panelist, "FTC and DOJ Issue Antitrust Guidance to HR Professionals: What You Need to Know," Ballard Spahr webinar, November 11, 2016
Panelist, "Let’s Make A Deal – Public and Private Antitrust Challenges to Health Care Combinations," Ballard Spahr Health Care Practice Group webinar, May 10, 2016
Panelist, "Where are we on Class Certification? Examples from Health Care and Pharmaceutical Cases," ABA Section of Antitrust Law, March 15, 2016
Panelist, "Back to the Future: A CLE Focused on Antitrust Basics, the Evolution of Antitrust Law, and Ethical Pitfalls," Ballard Spahr CLE Program, November 16, 2015
Panelist, "The New Antitrust Paradigm: Increased Enforcement and Opportunity," DELVACCA Health Biotech & Pharma CLE Institute, King of Prussia, Pa., June 5, 2014
"Antitrust Challenges to Patent Settlements after FTC v. Actavis," Ballard Spahr webinar, June 25, 2013
Panelist, "FDA Citizen Petitions and Noerr Immunity: Policy Questions and Litigation Tactics to Consider," American Bar Association Section of Antitrust Law, Exemptions & Immunities and Health Care & Pharmaceuticals Committees program, November 5, 2012
"Antitrust Briefing – A Look at Current Litigation and Enforcement Trends," Ballard Spahr CLE, Philadelphia, July 18, 2012
Panelist, "With or Without Merit, Class Certification Requires Commonality," American Bar Association Section of Antitrust Law, 59th Antitrust Law Spring Meeting, Washington, D.C., March 30, 2011
Panelist, "New Mood in Antitrust," Ballard Spahr CLE for Free, June 16, 2009
"Antitrust and Intellectual Property: Patents, Pitfalls and Potential Profits," 2007
"Successful Joint Venturing: Avoiding Antitrust Issues," executive briefing on "Current Trends: Successful Joint Venturing with For-Profit and Nonprofit Entities," Fall 2003
"Record Retention Policies, Related Issues, and Ethical Considerations," Ballard Spahr Women's Marketing Group
Panelist, "Defense Symposium for In-House Counsel: Avoiding Litigation Disasters," DuPont Primary Law Firm Network